Literature DB >> 21981770

Histopathologic characterization of mild rejection (grade I) in skin biopsies of human hand allografts.

Theresa Hautz1, Bettina Zelger, Gerald Brandacher, Hansgeorg Mueller, Johanna Grahammer, Bernhard Zelger, Andrew W P Lee, Pedro Cavadas, Raimund Margreiter, Johann Pratschke, Stefan Schneeberger.   

Abstract

Mild skin rejection is a common observation in reconstructive transplantation. To enlighten the role of this inflammatory reaction we investigated markers for cellular and antibody mediated rejection, adhesion molecules and tolerance markers. Forty-seven skin biopsies (rejection grade I) of human hand allografts were investigated by immunohistochemistry (CD3, CD4, CD8, CD20, CD68, C4d, LFA-1, ICAM-1, E-selectin, P-selectin, VE-cadherin, HLA-DR, IDO, and Foxp3). Expression was read with respect to time after transplant. The infiltrate was mainly comprised of CD3+T-lymphocytes. Among these, CD8+cells were more prominent than CD4+cells. CD20+B-lymphocytes were sparse and CD68+macrophages were found in some, but not all samples (approximately 10% of the infiltrate). The CD4/CD8-ratio was increased after the first year. C4d staining was mainly positive in samples at time-points later than 1 year. Adhesion molecules LFA-1, ICAM-1, E-selectin, P-selectin, and VE-cadherin were found upregulated, and for P-selectin, expression increased with time after transplant. IDO expression was strongest at 3 months-1 year post-transplant and a tendency toward more Foxp3+ cells at later time points was observed. Mild skin rejection after hand transplantation presents with a T-cell dominated dermal cell infiltrate and upregulation of adhesion molecules. The role of C4d expression after year one remains to be elucidated.
© 2011 The Authors. Transplant International © 2011 European Society for Organ Transplantation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21981770     DOI: 10.1111/j.1432-2277.2011.01369.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  7 in total

Review 1.  Facial and hand allotransplantation.

Authors:  Bohdan Pomahac; Ryan M Gobble; Stefan Schneeberger
Journal:  Cold Spring Harb Perspect Med       Date:  2014-03-01       Impact factor: 6.915

Review 2.  Accommodation and related conditions in vascularized composite allografts.

Authors:  Jeffrey L Platt; Christina L Kaufman; Mayara Garcia de Mattos Barbosa; Marilia Cascalho
Journal:  Curr Opin Organ Transplant       Date:  2017-10       Impact factor: 2.640

Review 3.  Vascularized composite tissue allotransplantation--state of the art.

Authors:  J Rodrigo Diaz-Siso; Ericka M Bueno; Geoffroy C Sisk; Francisco M Marty; Bohdan Pomahac; Stefan G Tullius
Journal:  Clin Transplant       Date:  2013-04-14       Impact factor: 2.863

4.  The Evolving Clinical Presentation of Acute Rejection in Facial Transplantation.

Authors:  Valentin Haug; Branislav Kollar; Doha Obed; Harriet Kiwanuka; Marvee Turk; Luccie Wo; Sotirios Tasigiorgos; Maximillian Kueckelhaus; Leonardo V Riella; Bohdan Pomahac
Journal:  JAMA Facial Plast Surg       Date:  2019-07-01       Impact factor: 4.611

5.  Improved Cuff Technique and Intraoperative Detection of Vascular Complications for Hind Limb Transplantation in Mice.

Authors:  Minhyung Kim; Daniel T Fisher; Colin A Powers; Elizabeth A Repasky; Joseph J Skitzki
Journal:  Transplant Direct       Date:  2018-02-02

Review 6.  Mechanisms and mediators of inflammation: potential models for skin rejection and targeted therapy in vascularized composite allotransplantation.

Authors:  Theresa Hautz; Dolores Wolfram; Johanna Grahammer; Ravi Starzl; Christoph Krapf; Johann Pratschke; W P Andrew Lee; Gerald Brandacher; Stefan Schneeberger
Journal:  Clin Dev Immunol       Date:  2012-09-19

Review 7.  A critical analysis of rejection in vascularized composite allotransplantation: clinical, cellular and molecular aspects, current challenges, and novel concepts.

Authors:  Karim A Sarhane; Sami H Tuffaha; Justin M Broyles; Amir E Ibrahim; Saami Khalifian; Pablo Baltodano; Gabriel F Santiago; Mohammed Alrakan; Zuhaib Ibrahim
Journal:  Front Immunol       Date:  2013-11-25       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.